CHICAGO–Integrated Genomics, Inc., a provider of bioinformatics products and services for the life sciences industry, has announced it has named Jonathan M. Sheridan to the position of President and Chief Executive Officer, succeeding Dr. John Elling who will remain Chairman of the Board.

Prior to Integrated Genomics, Mr. Sheridan was VP Commercial Operations HTG Inc. where he was responsible for forming new business partnerships with pharmaceutical and life sciences companies, establishing research agreements with academic institutions, and managing the global commercial sales and marketing teams. Mr. Sheridan also held senior positions with PerkinElmer Life and Analytical Sciences, Epicentre Biotechnologies, Genomica, Lion Biosciences, PerkinElmer Cetus, Beckman Coulter, and Monsanto.

“Jonathan Sheridan is a proven executive with an exceptional blend of strategic, business and leadership skills,” said Elling. “We are confident that he is the ideal person to sustain IG’s strong performance and lead the Company in the next phase of its growth.”

“I am excited about the potential that IG presents. Integrated Genomics ERGO™ platform is the leading genomic tool for microbial systems biology and IG is on the verge of becoming the leader in microbial metabolic engineering,” stated Mr. Sheridan.